The breadth of topics being presented at ASCRS by ECP physicians emphasizes the company’s culture of innovation and continuous learning. It also underscores the possibility of a career “third pathway” which allows physicians to conduct industry-leading research while also continuing to build a clinical practice.

“EyeCare Partners has a strong representation of ophthalmologists presenting research at ASCRS this year, in addition to one of our specialists, Dr. Elizabeth Yeu, serving as the incoming president of ASCRS,” said David Clark, CEO of EyeCare Partners. “We are committed to elevating eye care, and we are proud to work with many ophthalmologists who are leading educators in their field and committed to advancing eye care through innovation and clinical research.”

Select ECP physician presentations at ASCRS include:

• “Prospective Evaluation of Eye Drop Self-Administration Accuracy in a Real-World Patient Population” – Alison Early, M.D., Cincinnati Eye Institute
• “Cardiovascular Effects of Immunosuppression for Ocular Surface Stem Cell Transplantation” – Albert Y. Cheung, M.D., Virginia Eye Consultants
• “Treatment of Corneal Neovascularization Prior to Deep Anterior Lamellar Keratoplasty” – Albert Cheung, M.D., Virginia Eye Consultants
• “Corneal Healing after Cenegermin Treatment in Patients with Stage 1 Neurotrophic Keratopathy” – Gregg Berdy M.D., Ophthalmology Associates
• “Cryopreserved Amniotic Membrane during Pterygium Excision: Health Economic Opportunity Analysis” – Neel Desai, M.D., Eye Institute of West Florida
• “Surgeon and Patient Experience Following Toric IOL Alignment with and without a Novel Ocular Registration-Guided Graphical Overlay System” – Robert Weinstock, M.D., Eye Institute of West Florida
• “Retrospective Assessment of the Routine Use of Loteprednol Etabonate Gel 0.38% Following LASIK and PRK Surgery” – Joseph Gira, M.D., Ophthalmology Associates
• “Interim Assessment of Safety & Efficacy of Human Corneal Endothelial Cell Therapy for Corneal Edema Secondary to Endothelial Dysfunction” – Edward Holland, M.D., Cincinnati Eye Institute
• “A Trifocal Lens with New Hydrophobic Acrylic Lens Material: A Study of Patient Satisfaction and Visual Performance” – Michael Jones, M.D., Quantum Vision Centers
• “EW-6 Be part of History in the making…The Big Bang in surgical visualization systems has arrived” – Caroline Watson, M.D., Alabama Vision Center, John Kitchens, M.D., Retina Associates of Kentucky
• “Axial Length Related Visual Outcomes in an Extended Depth of Focus Lens Implantation” – Rohit Krishna, M.D., Sabates Eye Centers
• “Sublingual Midazolam and Ketamine for Surgical Sedation, a Multicenter, Double Masked, Randomized Controlled Trial” – Michael Nordlund, M.D., Ph.D., Cincinnati Eye Institute
• “Visual Outcomes of the Tecnis Symfony Lens in Patients with Ocular Hypertension and Mild to Moderate Glaucoma” – Constance Okeke, M.D., Virginia Eye Consultants
• “IC-124 Management of Complications Encountered during Cataract Surgery” – Robert Osher, M.D., Cincinnati Eye Institute
• “STL-2 Iris Prothesis” – Samantha Schockman, M.D., Cincinnati Eye Institute
• “Real-World Outcomes of Intranasal Varenicline for the Treatment of Dry Eye Disease” – Amar Shah, M.D., Cincinnati Eye Institute
• “Sterile and Infectious Infiltrates after Epithelial Defect Treatment with Cryopreserved and Dehydrated Amniotic Membrane: A Case Series” – John D. Sheppard, M.D., Virginia Eye Consultants
• “Refractive impact of topical meds” – Kavitha Sivaraman, M.D., Cincinnati Eye Institute
• “IC-001 The Wonderful World of Iris Prostheses: A Case-Based Compendium” – Michael Snyder, M.D., Cincinnati Eye Institute
• “Eyeninja - Danger in the Dark: Introducing the Eidolon Handheld Slit Beam” – Lawrence Tenkman, M.D., John-Kenyon Eye Centers
• “Can’t Touch That!” – Megan Tuohy, M.D., Cincinnati Eye Institute, Michael Snyder, M.D., Cincinnati Eye Institute
• “Effectiveness of Femtosecond Laser Assisted Cataract Surgery and Manual Phacoemulsification during the Learning Curve of Fellows in Training” – Robert Weinstock, M.D., Eye Institute of West Florida
• “Safety & Efficacy of Lotilaner Ophthalmic Solution, 0.25% in Treating Demodex Blepharitis: Combined Analysis of Two Pivotal Trials” – Elizabeth Yeu, M.D., Virginia Eye Consultants
• “CSF-1 (0.4% Pilocarpine HCl Ophthalmic Solution) for the Treatment of Presbyopia: Near-1 and Near-2 Phase 3 Clinical Trials” – Edward J. Holland, M.D., Cincinnati Eye Institute
• “Effects of Uncrosslinking Ocular Rigidity in Aging Eyes: Rejuvenation of Visual Age Utilizing a New Microporation Therapy” – Elizabeth Yeu, M.D., Virginia Eye Consultants
• “Prospective, Randomized, Contralateral Eye Study of Femtosecond Laser Assisted Cataract Surgery and Manual Phacoemulsification” – Robert Weinstock, M.D., Eye Institute of West Florida
• “Interim Assessment of Safety & Efficacy of Human Corneal Endothelial Cell Therapy for Corneal Edema Secondary to Endothelial Dysfunction” – Elizabeth Yeu, M.D., Virginia Eye Consultants
• “Efficiency of a water-free topical cyclosporine in the treatment of dry eye disease (DED) in patients with or without cataract” – John D. Sheppard, M.D., Virginia Eye Consultants
• “Changes in Creatinine Levels Related to Tacrolimus Used for Ocular Surface Stem Cell Transplantation” – Albert Y. Cheung, M.D., Virginia Eye Consultants

About EyeCare Partners

EyeCare Partners is the nation’s leading provider of clinically integrated eye care. Our national network of over 300 ophthalmologists and 700 optometrists provides a lifetime of care to our patients with a mission to enhance vision, advance eye care and improve lives. Based in St. Louis, Missouri, over 700 ECP-affiliated practice locations provide services that span the eye care continuum in 18 states and 30 markets. For more information, visit www.eyecare-partners.com and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230504005700/en/